Antonio Pera

Antonio Pera

Direttore/Membro del Consiglio presso ANI PHARMACEUTICALS, INC.

Patrimonio netto: 2 M $ in data 30/06/2026

68 anni
Health Technology
Consumer Services
Commercial Services

Profilo

Antonio R.
Pera
is the founder of Bedford Laboratories, Inc., founded in 2000.
Mr. Pera currently serves as an Independent Director at ANI Pharmaceuticals, Inc. since 2020.
Mr. Pera is Secretary & Treasurer at the Association for Accessible Medicines and a Member of the Licensing Executives Society.
Former positions include President at Endo Generics Holdings, Inc. from 2016 to 2019, Senior Vice President-Supply Chain Management at Cencora, Inc., Head-US Generic Business at American Pharmaceutical Partners, Inc., President at Par Pharmaceutical, Inc. from 2013 to 2019, and Senior Vice President-Commercial Operations at Par Sterile Products LLC.
Education includes an MBA from DePaul University and undergraduate studies at the University of Illinois.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
21/05/2026 27.017 ( 0,12% ) 2 M $ 30/06/2026

Posizioni attive di Antonio Pera

SocietàPosizioneInizio
ANI PHARMACEUTICALS, INC. Direttore/Membro del Consiglio 06/08/2020
Corporate Officer/Principal 04/08/2009
Segretario Aziendale -

Precedenti posizioni note di Antonio Pera

SocietàPosizioneFine
PAR PHARMACEUTICAL COMPANIES, INC. Presidente 02/08/2019
Presidente 01/08/2019
Fondatore -
Corporate Officer/Principal 20/04/2006
Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Antonio Pera

Formazione di Antonio Pera

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

86

Relazioni di 1° grado

11

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private11

Health Technology

Health Technology

Distribution Services

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Commercial Services

Commercial Services

Health Technology

  1. Mercati
  2. Insiders
  3. Antonio Pera